Related Experiment Video

Updated: Mar 18, 2026

Implantation of an Isoproterenol Mini-Pump to Induce Heart Failure in Mice
05:08

Implantation of an Isoproterenol Mini-Pump to Induce Heart Failure in Mice

Published on: October 3, 2019

12.1K

Adrenal GRK2 upregulation mediates sympathetic overdrive in heart failure

Anastasios Lymperopoulos1, Giuseppe Rengo, Hajime Funakoshi

  • 1Center for Translational Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.

Nature Medicine
|February 27, 2007
PubMed

Insights

Sympathetic nervous system (SNS) hyperactivity in heart failure involves adrenal alpha2AR dysregulation. Inhibiting adrenal G protein-coupled receptor kinase 2 (GRK2) lowers catecholamines and improves heart function, revealing a new therapeutic target.

Area of Science:

  • Cardiology
  • Neuroendocrinology
  • Molecular Pharmacology

Background:

  • Sympathetic nervous system (SNS) hyperactivity is key in heart failure, evidenced by high catecholamines.
  • Existing sympatholytic therapies targeting alpha2-adrenergic receptors (alpha2AR) have shown limited success in heart failure.

Purpose of the Study:

  • To investigate adrenal adrenergic receptor signaling in heart failure.
  • To elucidate molecular mechanisms behind the failure of alpha2AR-targeting sympatholytic agents.
  • To identify novel strategies for reducing SNS activity in heart failure.

Main Methods:

  • Utilized heart failure models to examine adrenal adrenergic receptor signaling.
  • Investigated the role of G protein-coupled receptor kinase 2 (GRK2) in alpha2AR regulation.
  • Employed adrenal gland-specific GRK2 inhibition.

Main Results:

  • Identified significant alpha2AR dysregulation in the adrenal gland during heart failure, linked to increased GRK2 expression and activity.
  • Adrenal-specific GRK2 inhibition normalized alpha2AR signaling, reduced plasma catecholamines, and improved cardiac function.
  • Enhanced the efficacy of alpha2AR agonists in heart failure models.

Conclusions:

  • Discovered a novel molecular mechanism underlying SNS hyperactivity in heart failure.
  • Adrenal GRK2 activity is a critical factor in alpha2AR dysregulation.
  • Adrenal GRK2 inhibition presents a promising new therapeutic strategy for heart failure.

More Related Videos

Quantifying Acute Changes in Renal Sympathetic Nerve Activity in Response to Central Nervous System Manipulations in Anesthetized Rats06:30

Quantifying Acute Changes in Renal Sympathetic Nerve Activity in Response to Central Nervous System Manipulations in Anesthetized Rats

Published on: September 11, 2018

8.4K
Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors12:03

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

Published on: June 7, 2016

18.5K

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.3K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.3K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
8.1K
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
2.2K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.4K